Whooping cough rates soar; shots urged

Share this article:

Adults over age 65 are being pushed with more emphasis to get the whooping cough (tetanus-diphtheria-acellular pertussis/Tdap) vaccine, which researchers have found to be as safe and effective in the senior population as a traditional tetanus and diphtheria vaccine.

As more adults receive the Tdap shot, an “evaluation of the safety of the vaccine in this population becomes essential,” said Hung Fu Tseng, Ph.D., Kaiser Permanente Southern California Department of Research & Evaluation.

There were 119,573 participants in the study who received the Tdap at one of seven Kaiser Permanente locations between January 2006 and December 2010. The same number received the TD vaccine. The risk for adverse post-vaccination reactions was comparable and minimal between both groups.

More adults are being vaccinated due to the spiking rate of infants contracting whooping cough, experts say. Infants younger than a year have the greatest risk and mortality from the disease, as they cannot be vaccinated until they are 2 months old. 

The findings were published in Clinical Infectious Diseases


Share this article:

More in News

Long-term care continues to lead in deal volume and value: PwC report

Long-term care continues to lead in deal volume ...

Long-term care bucked healthcare industry trends with strong merger and acquisition activity in the second quarter of 2014, according to newly released data from professional services firm PricewaterhouseCoopers.

Empowering nurse practitioners could reduce hospitalizations from SNFs, study finds

Granting more authority to nurse practitioners is associated with reduced hospitalization of skilled nursing facility residents, according to recently published findings.

Pioneer ACO drops out of program, despite reductions in skilled nursing utilization

A California healthcare system has become the latest dropout from the Pioneer Accountable Care Organization program, despite reducing skilled nursing facility utilization and improving its readmission rates. Sharp HealthCare announced its decision in a quarterly financial statement released Tuesday.